Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2007-002681-34-GB
EUCTR2007-002681-34-GB
Active, not recruiting
Phase 1

Dual antiplatelet therapy in the acute phase following stroke and TIA; which is the best regimen?

St Georges Healthcare NHS Trust0 sites0 target enrollmentAugust 2, 2007
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsSymptomatic carotid artery stenosisMedDRA version: 9.1 Level: LLT Classification code 10007687 Term: Carotid artery stenosis
DrugsPlavixPersantin

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Symptomatic carotid artery stenosis
Sponsor
St Georges Healthcare NHS Trust
Status
Active, not recruiting
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 2, 2007
End Date
July 3, 2008
Last Updated
6 years ago
Study Type
Interventional clinical trial of medicinal product

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Patients with greater than or equal to 50% carotid artery stenosis AND symptoms of transient ischaemic attack or stroke within the last month.
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) yes
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •1\. antiplatelet/antithrombotic medication other than aspirin (although low does prophylactic subcutaneous heparin for DVT prophylaxis will be allowed)
  • •2\. patients with prosthetic heart valves who have gaseous embolic signals.
  • •3\. patients in who clopidogrel or dipyridamole are contraindicated.
  • •4\. If carotid endarterectomy is planned during the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
What is the best treatment after stroke?
ISRCTN68019845St George's Heathcare NHS Trust (UK)60
Completed
Not Applicable
oborI dual antiplatelet therapy as aPPropriate duratiON (NIPPON)Coronary Artery Disease
JPRN-UMIN000006698PO Associations for Establishment of Evidence in Interventions4,598
Active, not recruiting
Not Applicable
ACUTE-PRAS
JPRN-jRCTs031220079Fujimoto Shigeru200
Active, not recruiting
Phase 1
Single versus Dual Antiplatelet Therapy in patients with Incomplete Revascularization after Coronary artery bypass graft surgery
EUCTR2017-001754-33-ITIVERSITÀ CAMPUS BIO-MEDICO DI ROMA800
Completed
Phase 4
Duration of Dual Anti-Platelet Therapy (DUAL-ACS)Acute Coronary SyndromeCoronary Artery Disease
NCT03252249University of Edinburgh5,094